Protein Kinase C Inhibition Overcomes Targeted Therapy Resistance in Cutaneous MelanomaCorinne I. Stoffel(University of Zurich), Mitchell P. Levesque(University of Zurich)Experimental DermatologyApril 1, 202510.1111/exd.70093Cited by 1SaveCiteExport RISWatch citationsRelated PapersROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma|Cancer Research|2023|24The Tumor Profiler Study: Integrated, multi-omic, functional tumor profiling for clinical decision support|medRxiv|2020|20Suppl. Figure S14 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma|Unknown|2023|0